Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors
Sign Up to like & getrecommendations! Published in 2018 at "BioMed Research International"
DOI: 10.1155/2018/2617439
Abstract: The role of cystatin C (Cys-C) in tumorigenesis and progression of bladder urothelial tumors (BUT) is still indefinite. We retrospectively collected the clinical information from the records of 425 BUT patients. Pretreatment serum Cys-C levels… read more here.
Keywords: urothelial tumors; bladder urothelial; level promising; clinicopathological characteristics ... See more keywords
Standardization of Body Composition Status in Patients with Advanced Urothelial Tumors: The Role of a CT-Based AI-Powered Software for the Assessment of Sarcopenia and Patient Outcome Correlation
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15112968
Abstract: Simple Summary Artificial Intelligence (AI)-driven software that utilizes Computed Tomography (CT)images has the capability to automatically assess body composition and diagnose sarcopenia. Our research indicates that combining standardized CT staging methods with sarcopenia analysis could… read more here.
Keywords: software; body composition; powered software; advanced urothelial ... See more keywords
The influence of post-diuretic late phase imaging in visual and quantitative evaluation of urothelial tumors by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Sign Up to like & getrecommendations! Published in 2019 at "Turkish journal of urology"
DOI: 10.5152/tud.2019.27482
Abstract: OBJECTIVE Although F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a valuable imaging method in most of the malignant tumors, it is considered to have limited diagnostic ability in urothelial tumors due to high… read more here.
Keywords: phase; urothelial tumors; visual quantitative; post diuretic ... See more keywords